Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years
European Journal of Cardio-Thoracic Surgery, 06/18/08
Print     Email This Article     Save in My Library   Free Abstract
Internullo E et al. – Pts >= age 76 yrs with esophageal or GEJ cancer may be surgical candidates based on findings of outcome and long-term results similar to those for younger pts; however, reliable individual risk-analysis stratification is still lacking

Methods

  • Retrospective analysis of outcome after esophagectomy for cancer of the esophagus and GEJ in 108 pts age >= 75 yrs
  • Pts: 76 males/32 females; mean age 79.5 yrs; mean standardized life-expectancy: 7.36 yrs
  • Analysis of comorbidities, outcome, and long-term survival
  • Assessment of pstoperative mortality risk: P-POSSUM and O-POSSUM score for in-hospital mortality; Steyerberg's score system for 30-day mortality
  • Comparison of 5-yr survival with standardized survival in general population

Results
  • Esophageal tumors, 69% of pts; GEJ tumors, 31%
  • Predominant histology: adenocarcinoma (74%); >=1 major comorbidities or a history of previous major upper-GI surgery, potentially affecting surgical outcome in 86 pts (79.6%)
  • All underwent resection with curative intent (R0 83.3%, R1 12%, R2 4.6%)
  • Overall postoperative morbidity: 51.9%; pulmonary complications most frequent (37%)
  • Postoperative mortality: mainly due to cardiopulmonary complications, (7.4%); consistent with prediction by P-POSSUM score (7.2%); lower than prediction by O-POSSUM score (15.1%)
  • 30-day mortality: 5.5%; consistent with prediction by Steyerberg's score (6.8%)
  • Overall 5-yr survival: 35.7%; R0 overall survival, 42%; cancer specific R0 survival, 51.7%

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.